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Abstract
The relative importance of environmental hypoxia due to global climate change on organismal ability to adapt to chemical
insult and/or mechanisms of these responses is not well understood. Therefore, we have studied the effects of combined
exposure to perfluorooctane sulfonamide (PFOSA) and chemically induced hypoxia on membrane lipid profile and
homeostasis. Primary salmon hepatocytes were exposed to PFOSA at 0, 25 and 50 mM singly or in combination with either
cobalt chloride (CoCl2: 0 and 150 mM) or deferroxamine (DFO: 0 and 100 mM) for 24 and 48 h. CoCl2 and DFO were used to
induce cellular hypoxia because these two chemicals have been commonly used in animal experiments for this purpose and
have been shown to increase hypoxia-inducible factor 1-alpha (HIF-1a) and vascular endothelial growth factor (VEGF) levels.
Fatty acid (FA) profiles were determined by GC-MS, while gene expression patterns were determined by quantitative PCR.
Hypoxic condition was confirmed with time-related increases of HIF-1a mRNA levels in CoCl2 and DFO exposed cells. In
general, significant alterations of genes involved in lipid homeostasis were predominantly observed after 48 h exposure.
Gene expression analysis showed that biological responses related to peroxisome proliferation (peroxisome proliferator-
activated receptors (PPARs) and acyl coenzyme A (ACOX)) and FA desaturation (D5- and D6-desaturases: FAD5 and FAD6,
respectively) and elongation (FAE) were elevated slightly by single exposure (i.e. either PFOSA, CoCl2 or DFO exposure
alone), and these responses were potentiated in combined exposure conditions. Principal component analysis (PCA)
showed a clustering of peroxisome proliferation responses at transcript levels and FA desaturation against membrane FAs
levels whose changes were explained by PFOSA and chemically induced hypoxia exposures. Overall, our data show that
most of the observed responses were stronger in combined stressor exposure conditions, compared to individual stressor
exposure. In general, our data show that hypoxia may, singly or in combination with PFOSA produce deleterious health,
physiological and developmental consequences through the alteration of membrane lipid profile in organisms.
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Introduction
Anthropogenic activities leading to the emissions of carbon
dioxide (CO2) and other greenhouse gases is thought to be the
main contributor to climate change [1]. In the aquatic environ-
ment, effects of climate change have already been observed as
increases in temperature and CO2 [2]. A consequence of increased
water temperature is reduction in partial pressure of oxygen (pO2),
and its availability to aquatic organisms [3,4]. Oxygen is crucial
for cellular respiration that generates energy for maintenance
processes and development in aerobic organisms [5]. Thus,
hypoxia (a quantifiable measure of climate change) may, singly
or in combination with emerging pollutants such as perflourinated
compounds (PFCs) produce deleterious physiological responses
that may reduce general health conditions and impaired
development in organisms [6].
Emerging compounds such as poly- and perfluoroalkyl
substances (PFASs), organophosphate flame-retardants, detergent
compounds, and several pharmaceutical substances have been
linked to several biological effects in organisms and are continu-
ously detected in the environment [7,8]. PFASs are manufactured
and used in various industrial and consumer products such as
fluorinated polymers, surfactants, insecticides and aqueous fire-
fighting foams [7]. In more than 50 years, 3M Company was the
major producer of perfluorooctane sulfonyl fluoride (POSF)
starting from 1949, but they have voluntarily phased out
production in 2002 [9]. POSF is the precursor to several PFCs,
whose reaction with methyl or ethylamides yields alkyl substituted
sulfonamides: N-methyl perfluorooctane sulfonamide (NMeFOSA)
and N-ethyl perfluorooctane sulfonamide (NEtFOSA), respective-
ly. Further dealkylation can generate perfluorooctane sulfonamide
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(PFOSA), which is randomly distributed in biota and has been
detected worldwide in fish, mammals, birds and humans at
concentrations in the range of 1–100 ng/g wet weight of tissue
[10,11]. The chemical properties of PFOSA make the compound
neither hydrophilic nor lipophilic and has been found to bind to
carrier proteins, such as albumin, in blood [12]. PFASs can appear
as both perfluorinated sulfonic (PFSAs) and carboxylic acids
(PFCAs) which have been shown to exert a variety of biological
effects, including – lipid homeostasis and peroxisome proliferation,
hepatomegaly, immunotoxicity, uncoupling of mitochondrial
oxidative phosphorylation, developmental toxicity, reduction of
thyroid hormone circulation, necrosis, down-regulation of hepatic
transporters and tumors [13,14,15,16]. In mammalian systems,
PFOSA was shown to undergo metabolic degradation at a slow
rate to form PFOS, and can also undergo enterohepatic
circulation, and mediate oxidative stress responses [17,18].
Energy homeostasis and its regulation is critical for normal
physiology and survival, and disruption of this balance often leads
to chronic disease state [19]. FAs in fish tissues are present in
different lipid classes and with different functions [20,21]. There
are two classes of essential long chain polyunsaturated fatty acids
(PUFAs) omega-3 (n-3s) and omega-6 (n-6s), based on the location
of the first double bond in the third (n-3) or sixth (n-6) position
from the methyl end of the aliphatic carbon chain [22].
Conversions of these essential fatty acids (FAs) are orchestrated
by several fatty acid desaturases (FADs) and elongase (FAE). Of
the n-3 PUFAs, a-linolenic acid (ALA: 18:3n-3) can be desaturated
and elongated to form eicosapentaenoic acid (EPA: 20:5n-3)
through the activity of FAD6, FAE and FAD5, further transfor-
mation involves FAD4 and FAE to docosahexaenoic acid (DHA:
22:6n-3) and is reversible. Whereas the n-6 PUFAs, linolelaidic
acid (LA: 18:2n-6) can be desaturated by FAD6 to c-linolenic acid
(GLA: 18:3n-6) and elongated by FAE to dihomo-c-linolenic acid
(DGLA: 18:3n-6) and further desaturation by FAD5 produces
arachidonic acid (ARA: 20:4n-6). ARA can thereafter through
steps involving FAD4 and FAE transform into docosapentaenoic
acid (DPA: 22:5n-6), and this last step is reversible.
Chemically-mediated changes in the composition of lipids will
affect many biological processes in the body, including lipogenesis,
lipid transport, deposition and storage, peroxisome proliferation,
and FA uptake in tissues and membrane fluidity [23]. Peroxisome
proliferator-activated receptors (PPARs) are known to be critical
regulators of lipid homeostasis by controlling the balance between
burning and storage of long FAs [24]. PPARs are ligand-
dependent transcription factors belonging to the nuclear hormone
receptor superfamily [24]. The acyl coenzyme A (ACOX)
catalyses the rate limiting-step in peroxisomal b-oxidation pathway
of FA, and is commonly used as a biomarker for peroxisomal
proliferation [24]. ACOX encoding gene in rats was regulated by
PPARs through a peroxisome proliferator response element
(PPRE) in the 59 upstream region of the gene[24]. Regulation of
peroxisome proliferation is controlled by PPARs and was first
identified having this function in frogs (Xenopus sp.) [25]. They
(PPARs) exert pleiotropic responses by regulating energy homeo-
stasis, adipose tissue differentiation and maintenance, cell prolif-
eration and tissue repair [26]. PPAR activities are consequently
changed in accordance with a wide variety of physiological
conditions, mediated through the ubiquitin-proteasome degrada-
tion system and extracellular signalling pathways and kinases that
lead to receptor phosphorylation [27]. Administration of food
containing PFOA induced peroxisome proliferation in Atlantic
salmon (Salmo salar) [28]. In rats the same treatment has shown
induced peroxisome proliferation and formation of benign liver
tumors [16].
In this study, we have investigated biological pathways related
to peroxisome proliferation, and lipid profile and homeostasis after
exposure to chemically induced hypoxia and PFOSA, given singly
and also in combination. Hypoxia was induced using cobalt
chloride (CoCl2) and deferoxamine mesylate (DFO), two chemi-
cals commonly used in animal experiments for this purpose and
have been shown to increase hypoxia-inducible factor 1-alpha
(HIF-1a) and vascular endothelial growth factor (VEGF) levels.
DFO induces hypoxia by chelating iron for excretion and
subsequently reducing the potential for oxygen transport [29]
and CoCl2 is known to inhibit iron-dependent hydroxylases,
resulting in an increase in HIF-1a protein accumulation, DNA
binding activity, and transactivation function including VEGF
induction [30,31]. Given that optimal physiological condition is
required for growth and development, optimal adaptation to
hypoxic stress may have detrimental consequences resulting from
inability to maintain physiological processes essential for normal
cellular functions. It may also produce diminished capacity to
handle fluctuation of other environmental factors that could
ultimately lead to reduction in general fitness [32,33,34] and
increase membrane (fluidity) passage for environmental contam-
inants. Our hypothesis is that exposure of salmon hepatocytes to
hypoxia, singly or in combination with PFOSA, will produce
significant changes in membrane lipid profile and biological
processes that regulate membrane lipid homeostasis, with overt
health, developmental, reproductive and physiological conse-
quences.
Materials and Methods
Chemicals and reagents
Highly pure (.98%) linear perfluorooctane sulfonamide
(PFOSA; CF3(CF2)7SO2NH2) isomer, as well as isotopically
labeled linear PFOSA-13C8 and linear PFOS-
13C4 were purchased
from Wellington Laboratories (Guelph, ON, Canada). iScript
cDNA Synthesis Kit and iTaq SYBR Green Supermix with ROX
were supplied by BioRad Laboratories (Hercules, CA, USA). The
original TA Cloning Kit PCR 2.1 vector, INVaF’ cells, TRIzol
and Dulbecco’s Modified Eagle Medium (DMEM) with non-
essential amino acid and without phenol red, fetal bovine serum
(FBS), 0.4% trypan blue and L-glutamine were purchased from
Gibco-Invitrogen Life Technologies (Carlsbad, CA, USA). Di-
methyl sulfoxide (DMSO), penicillin-streptomycin-neomycin solu-
tion, collagenase (C0130-1G), bovine serum albumin (BSA), N-[2-
Hydroxyethyl]piperazine-N’-[2-Ethane Sulfonic Acid] (HEPES),
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA),
ethyleneglycol bis-(b-aminoethylether)-N,N,N’,N’-tetraacetic acid
(EGTA), polyunsaturated fatty acid 1 and 2 (PUFA1 and PUFA2)
were purchased from Sigma-Aldrich Chemie GmbH (Munich,
Germany). Tricaine methane sulphonate (MS-222) was purchased
from Norsk Medisinaldepot AS. GelRed Nucleic Acid Gel Stain
was purchased from Biothium (Hayward, CA, USA). The ZR
Plasmid Miniprep-Classic was purchased from Zymo Research
(Orange, CA, USA).
Animals, exposure and sampling
All necessary permits were obtained from the Norwegian
Animal Research Authority for the described study, which
complied with all relevant regulations. Atlantic salmon (Salmo
salar) were purchased from Lundamo Hatcheries (hatch and
rearing centre located at Lundamo). Fish were kept at the animal-
holding facilities for Department of Biology (Sealab, NTNU) in
100-liter tanks with continuously running fresh water at 10uC and
flow rate of 40 L/h and natural photoperiod. Fish were
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acclimatized for two weeks and starved three days prior to liver
perfusion.
Collagenase perfusion, isolation and culture of
hepatocytes
Prior to liver perfusion, all glassware and instruments were
autoclaved and solutions were filtration sterilized by using 0.22 mm
Millipore filter (Millipore AS, Oslo, Norway). Fish were anesthe-
tised using MS-222 (70 g/L) administered 15 minutes prior to
perfusion and euthanized after in accordance with regulations for
animal research and approved by Norwegian Food Safety
Authority (FOTS). Hepatocytes were isolated from 10 individuals
by a two-step perfusion technique with modifications as previously
described [35]. The cell suspension was filtered through a 150 mM
nylon monofilament filter and centrifuged at 706g for 5 min.
Hepatocyte from individual fish were used across all individual
exposure scenarios in such a way that all 10 fish were represented
in all exposures. Cells were washed three times with serum-
containing medium and finally resuspended in complete medium.
Following collagenase perfusion and isolation of hepatocytes,
viability of cells was determined by the trypan blue exclusion
method. A cell viability value of .90% was a criterion for further
use of the cells. Cells were plated on 35 mm TPP Tissue Culture
Plates (Techno Plastic Products AG, Switzerland) at monolayer
density of 2.16106 cells in 3 ml DMEM medium (without phenol
red) containing 0.5% (v/v) FBS, 1% (v/v) L-glutamine, 15 mM
HEPES and 1% (v/v) antibiotic-antimycotic.
Plating of cells and exposure
Medium was added to plate prior to the cells, avoiding
sedimentation of cells by rotating the tube every second plate.
Cells were cultured at 10uC in a sterile incubator for 24 hours
prior to exposure. After 24 hours pre-culture, growth medium was
removed and quickly replaced with exposure medium (twenty
wells for each exposure group); to 0.1% DMSO (control), 150 mM
CoCl2, 100 mM DFO, 25 mM PFOSA (singly and in combination
with either 150 mM CoCl2 or 100 mM DFO), 50 mM PFOSA
(singly and in combination with either 150 mM CoCl2 or 100 mM
DFO). This gave a total of 9 different exposure groups. Media and
cells were harvested separately, ten wells for each exposure group
at 24 and 48 h, post-exposure and snap-frozen immediately in
liquid nitrogen. Cells used for RNA analysis were lysed in Trizol
reagent for total RNA isolation according to the manufacturer’s
protocol (Invitrogen).
Assessment of cell viability
A pilot study using different concentration (10, 50, 100, 150 and
200 mM) of CoCl2 or DFO was performed in order to determine
optimal exposure concentrations for hypoxia-inducing chemicals.
Evaluation was performed using resazurin assay on cells exposed
for 24 and 48 h in 96-well plates (2.16105 cells in 300 ml). After
addition of rezasurin solution (10% of medium volume), cells were
incubated for 6h at 10uC on a gyratory shaker. Samples were
measured spectrophotometrically at 600 nm every 20 minutes.
Viability was also investigated for all exposure groups (see below).
Quantitative (real-time) PCR
Total cDNA for quantitative real-time polymerase chain
reaction (q-PCR) analysis was generated from 1 mg total RNA
from all samples using a combination of poly-T and random
primers from iScript cDNA synthesis kit as described by the
manufacturer (Bio-rad). RNA samples were evaluated for integrity
using agarose gel electrophoresis. Quantitative real-time PCR was
used for evaluating gene expression profiles for HIF1-a, FAD5,
FAD6, FAE, ACOX and PPAR (a, b and c). For each treatment,
expression of individual gene targets was analyzed using the
Mx3000P REAL-TIME PCR SYSTEM (Stratagene, La Jolla,
CA, USA). Each 25 ml qPCR reaction contained - 12.5 ml of
iTAQ SYBR Green Supermix with ROX (Bio-Rad), 1 ml of
cDNA, 200 nM of each forward and reverse primers and
remaining volume was autoclaved MQ-H2O. The three-step
real-time PCR program included an enzyme activation step at
95uC (5 min) and 40 cycles of 95uC (30 s), 55–65uC (30 s)
(depending on the primers used; see Table 1), and 72uC (30 s).
Controls lacking a cDNA template were included to determine the
specificity of target cDNA amplification. Cycle threshold (Ct)
values obtained were converted into mRNA copy number using
standard plots of Ct-value versus log copy number. The criterion
for using the standard curve is based on equal amplification
efficiency (usually 90%) with unknown samples and this is checked
prior to extrapolating unknown samples to the standard curve.
The standard plots were generated for each target sequence using
known amounts of plasmid containing the amplicon of interest, as
described previously by [36]. Data from each group were averaged
and expressed as percentage of control.
FA extraction and GC-MS analysis
Lipids were extracted from Atlantic salmon hepatocytes by
homogenization in chloroform: methanol (2:1) solution, added
with 0.01% of 2,6-di-tert-butyl-4-methylphenol (BHT) as an
antioxidant, according to the method of Folch et al [37]. FA
methyl esters (FAMEs) from total lipids were prepared by acid-
catalyzed transmethylation for 1 h at 100uC, using tricosanoic acid
(23:0) as internal standard. Methyl esters were extracted by c-
hexane, then dried by centrivap, weighed and suspended in c-
hexane (1% v/v). FAMEs analysis was performed using a
Shimadzu GC-MS 2010 gas chromatograph-mass spectrometer
and fitted with a fused silica capillary column (Supelco, Germany)
and helium was used as carrier gas. The injector, detector and
column temperatures were 250uC, 300uC and 200uC, respectively.
Relative percentage of the area was obtained by using the
following equation: Area% FAX = [AX/AR]6100, where:
FAX = fatty acid to be quantified, AX = area of the methyl
esters, X and AR = total area of the chromatogram. Peak areas
lower than 0.1% of the total area was not considered. We
identified FA methyl esters by comparing retention time of
samples and standards.
Statistics
Data are presented as mean percent of control with the same
exposure duration 6 standard error of mean (SEM). Normal
distribution was assessed using Shapiro-Wilks test and homogene-
ity of variance was tested with Levene’s test. Comparison of
different concentrations of PFOSA treatment, singly or in
combination with CoCl2 or DFO, groups and control group was
done using One-way ANOVA with post-hoc (Tukey) using SPSS.
We used Simca-P 12 to perform multivariate analysis making
principal component analysis (PCA) plots. All observations and
variables of concern were investigated and based on distribution
patterns and group formation we chose which groups to
investigate further. Variables investigated here were Q-PCR data.
Observations (exposure groups) must be independent when
investigated using PCA, so data was separated on terms of
exposure duration (24 and 48 h). PCA biplot presented herein
were produced by first component (PC1) and second component
(PC2) and percent of variation (R2X) is displayed for each plot.
Combined Effects of Hypoxia and PFOSA on Lipid Homeostasis
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Results
Evaluation of cell viability and validation of hypoxia
exposure
Our pilot study showed that increasing DFO and CoCl2
concentration above 100 and 150 mM, respectively, noticeably
reduced cell viability. Cell viability in the different exposure
regimes showed a cell survival rate above 65% (data not shown).
Gene expression analysis of HIF-1a was used to assess the hypoxic
condition of the hepatocytes showing significant increase of
mRNA expression, at 48 h compared to 24 h post-exposure, in
combined exposure scenarios and by DFO alone. CoCl2 exposure
induced HIF-1a after both 24 and 48 h, albeit not significant.
HIF-1a mRNA was not induced by exposure to PFOSA alone
(Fig. 1).
Modulation of membrane FAs composition
Changes in membrane FA composition were observed after
PFOSA, CoCl2 and DFO exposures and these effects were
dependent on PFOSA concentration, combined exposure with
individual DFO or CoCl2 and FA type (Table 2). After 24 h,
exposure to DFO alone produced a significant reduction in ALA
(18:3n-3) levels, and combined low (25 mM) PFOSA in combina-
tion with CoCl2 or DFO increased ALA levels in salmon
hepatocytes (Table 2). High PFOSA (50 mM) exposure, singly or
in combination with CoCl2 or DFO, increased membrane ALA
levels at 24 h exposure (albeit not significant). Exposure of
hepatocytes to PFOSA or in combination with hypoxic condition
significantly reduced membrane levels of ARA (20:4n6) and EPA
(20:5n-3) after 24 h (Table 2). All exposure conditions produced
increases in 22:6n-3 (DHA) after 24 h. Linoleic acid (LA: 18:2n-6)
was increased in all exposure groups with CoCl2 and by 25 mM
combined with DFO, while combined 50 mM PFOSA and DFO
Table 1. Primer pair sequences, accession numbers, amplicon size and annealing temperature conditions for genes of interest
used for real-time PCR.
Target
Gene Primer sequence*
Amplicon size
(basepairs)
Annealing temperature
(6C)
Forward Reverse
Hif-1a GCT CAG AAA GTC GGT TGT CC GCC AGC TCG TAG AAC ACC TC 152 60
FAD5 GAC CTA TAT TTC CAG CAT TAT CC TCA CTC ATC TAC AAA TAG TAT TCC 192 55
FAD6 CAT CTG ATT CTG ATT CCA TTC C CTC TGC TCC ACT CAC ACC 127 55
FAE GAC ACC CAC GGA AAC CAT TAC CTC TCC TAG CGA CAT TAC ATA CAG 111 55
PPARa GCT TCA TCA CCA GGG AGT TT TCA CTG TCA TCC AGC TCC AG 113 60
PPARb CAA TGG CTC GGA TCT CAA AT ACT CTA CTG GGC TGG AGC TG 124 60
PPARc CAC TGT GAT CTG CAC TGT ATG GCA TCA TGT GAC ATT 100 60
*Sequences are given in the 59239order
doi:10.1371/journal.pone.0102485.t001
Figure 1. Changes in transcript levels for hypoxia-inducible factor 1a (HIF-1a) in salmon hepatocytes exposed to PFOSA (25 and
50 mM), singly or in combination with, either CoCl2 (150 mM) or DFO (100 mM) for 24 and 48 h. Transcripts were analyzed using real-time
polymerase chain reaction (qPCR) and expressed as mean percentage (%) of control6 SEM (n= 5). Asterisk (*) denotes significant difference (p,0.05)
compared to control analyzed by Tukey’s test, while diamond (¤) denotes significant difference (p,0.05) with individual hypoxia treatment group
(CoCl2 or DFO) at respective time-interval.
doi:10.1371/journal.pone.0102485.g001
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reduced LA level after 24 h (Table 2). Membrane ALA and GLA
were reduced by DFO after 24 h, but were generally increased by
other exposure regimes (Table 2). Membrane FA showed different
composition pattern at 24 h, compared to 48 h (Table 2 and 3). At
48 h, ARA was significantly reduced in all exposure groups, except
PFOSA that produced an increase. Membrane ARA levels were
significantly reduced by CoCl2 and DFO exposure alone,
compared with PFOSA exposure that increased ARA levels.
Combined exposure with PFOSA and DFO or CoCl2 sustained
the hypoxic condition mediated decrease on membrane ARA
levels (Table 3). Membrane EPA levels were reduced by CoCl2
and DFO exposures at 48 h, and combined exposure with PFOSA
concentrations significantly increased these effects, except com-
bined DFO and 50 mM PFOSA, that produced a significant
reduction (Table 3). While 25 mM PFOSA significantly reduced
EPA levels, 50 mM PFOSA significantly increased membrane EPA
levels after 48 h exposure (Table 3). Membrane LA levels were
significantly increased by CoCl2 and DFO exposures alone or in
combination with PFOSA concentrations at 48 h. On the other
hand, membrane ALA and GLA were significantly reduced by
CoCl2 and DFO exposure alone at 48 h, and combined exposure
with 25 mM PFOSA significantly increased (DFO) and decreased
(CoCl2) ALA levels, and the opposite is true for GLA at 48 h
(Table 3). All exposure conditions reduced membrane DHA levels
except combined DFO and 25 mM PFOSA, and combined CoCl2
and 50 mM PFOSA (Table 3).
Modulation of transcripts involved in fatty acid
metabolism
The effects of PFOSA, given singly or in combination with
CoCl2 or DFO on FAD5, FAD6 and FAE, showed unique and
comparable patterns after 24 and 48 h exposure (Fig. 2). Exposure
to PFOSA concentrations increased transcription of FAD5, FAD6
and FAE mRNA at 48 h, while no significant effects were
observed after 24 h (Fig. 2). The combined exposure of PFOSA
and CoCl2 or DFO significantly increased FAD5, FAD6 and FAE
transcripts at 48 h, while no significant effects were observed after
24 h exposure (Fig. 2A, B and C, respectively). Acyl-coenzyme A
oxidase (ACOX) was not significantly affected by PFOSA
exposure both at 24 and 48 h (Fig. 3). On the contrary, CoCl2
and DFO significantly increased ACOX mRNA expression at
48 h, and combined exposure with PFOSA concentrations
significantly sustained these effects at the same time interval
(Fig. 3). No effects were observed either when CoCl2 and DFO
were given singly, or in combination with PFOSA concentrations
at 24 h (Fig. 3).
Modulation of transcripts involved in lipid peroxidation
Gene expression levels of PPAR (a, b and c) were investigated in
all exposure groups (Fig. 4) showing that exposure to PFOSA
concentrations elevated PPARa mRNA levels at 48 h exposure
(Fig. 4A). Exposure to CoCl2 alone did not affect PPARa, but
combined exposure with PFOSA produced significant increase
after 48 h exposure (Fig. 4A). On the other hand, exposure to
DFO alone significantly increased PPARa mRNA at 48 h, and
combined exposure with PFOSA concentrations sustained this
effect, but with reduced expression levels in combination with
25 uM PFOSA (compared DFO exposure, Fig. 4A). For PPARb
and PPARc, no effects were observed after exposure to PFOSA
concentrations either at 24 or 48 h (Fig. 4B). On the other hand,
CoCl2 and produced increases in PPARb and PPARc expressions,
when given alone, and combined exposure with PFOSA
concentrations significantly sustained these effects at 48 h
(Fig. 4B and C, respectively). Otherwise, no significant PPARb
and PPARc transcriptional changes were observed after 24 h
exposure in any exposure group (Fig. 4B and C).
Principal component analysis (PCA)
A principal component analysis was used in order to explore
observations and variables with correlative patterns. We chose to
incorporate molecular responses (mRNA) as variables and all
comparable observations. At biplot analysis after 24 h exposure,
we observed that all observations were located around neutral
point (t[1] = 0, t[2] = 0) and there is no distinct distribution pattern
among or between groups. Variables were located in the right side
arc of the plot, and mostly explained by principal component 1
(PC1: 49.5%), except PPARb that is located closer to PC2 (18.8%:
Fig. 5A). There was no association between observations and
variables, and further evaluation of variables was not pursued.
Biplot of samples exposed for 48 h showed distribution along PC1
(74,9%), where observations were clustered, although somewhat
overlapping, related to separate exposure treatments (Fig. 5B).
PC1 (74.9%) explained most variation in this dataset and neither
the observations nor parameters were drawn particularly to PC2
(11.2%). Control, single PFOSA (25 or 50 mM) and single 150 mM
CoCl2 are located along PC1 and on the left side of PC2.
Combined PFOSA (25 and 50 mM) and CoCl2 are located further
right in biplot compared to control and 25 mM PFOSA group is
generally located above PC1 towards PPAR (a and c) and ACOX.
Some individual exposures are less described by the model and are
located close to neutral point. All groups containing DFO were
located left of PC2, showing several observations that are close to
PC1 or below (Fig. 5B). Variables that were distributed in an arc
along the outer ring at right side of the biplot were mainly
explained by PC1. In a longer distance away from PC1, were
PPARs, with PPARc and PPARa above PC1 and PPARb below,
while FAD5, FAD6, FAE, ACOX and HIF-1a are closer to PC1.
Generally, PC2 describes very little of the variation in this biplot
(Fig. 5B).
Discussion
Previously, it has been shown in several studies that PFASs
modulate the PPAR system and membrane FA homeostasis [38],
and through these pathways induce peroxisome proliferation and
oxidative stress responses [28,38,39]. Changes in the global
climate are currently observed as increases in temperature and
CO2 that subsequently produce reduction in oxygen partial
pressure (pO2), and its availability to aquatic organisms. Oxygen is
crucial for aerobic organisms that depend on it for cellular
respiration, and because reduced environmental oxygen saturation
(hypoxia) and environmental contaminants represent multiple
environmental stressor. Hypoxia has been associated with effects
on hormonal and biotransformation systems [40,41,42], and the
relative importance of environmental hypoxia on organismal
adaptive abilities responding to chemical insult are not well
understood. Therefore, the present study was designed to
investigate molecular and physiological effects of hypoxia and
PFOSA, given singly and also in combination, on membrane FA
composition and associated effects on molecular processes that
regulate lipid homeostasis in fish, using a salmon hepatocyte
in vitro model. Cellular hypoxia was induced using DFO and
CoCl2, two chemicals that are frequently used to induce hypoxia
in in vitro models, but also have an apoptotic potential [30].
Modulation of membrane fatty acid composition
Hepatocytes adapt to reduction in oxygen levels by shifting
energy production from mitochondrial fatty acid b-oxidation to
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glycolysis during periods of cellular hypoxia [43]. As a result, the
activation of the HIF complex represents an early response to
hypoxia exposure. Consequently, HIF is a central adaptive change
in response to hypoxia through HIF-mediated reprogramming of
cellular metabolism. Thus, HIF plays an integral role in switching
energetic usage from aerobic to anaerobic metabolism to generate
more ATP in an oxygen independent manner, through the
regulation of glucose transporter 1 and several critical glycolytic
enzymes, and to inhibit mitochondrial oxidative phosphorylation
[44]. Glucose metabolism under hypoxic conditions and the role
of HIF has been extensively studied, but less is known on its role in
lipid metabolism in response to low oxygen and possible
interaction with environmental contaminants. Recently, it was
shown that acute and intermittent hypoxia induced liver lipid
accumulation, suggesting a prominent role for HIF in regulating
hepatic membrane lipid composition and metabolism [45,46].
Figure 2. Modulation of FAD5 (A), FAD6 (B) and FAE (C) in salmon hepatocytes exposed to CoCl2 (150 mM) or DFO (100 mM), singly
or in combination with PFOSA (25 and 50 mM). Transcripts were analyzed using real-time polymerase chain reaction (qPCR) and expressed as
mean percentage (%) of control 6 SEM (n = 5). Asterisk (*) denotes significant difference (p,0.05) compared to control analyzed by Tukey’s test,
while diamond (¤) denotes significant difference (p,0.05) with individual hypoxia treatment group (CoCl2 or DFO) at respective time-interval.
doi:10.1371/journal.pone.0102485.g002
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In the present study, we observed significant increase in
transcript levels for HIF-1a mRNA expression after hypoxia
(DFO and CoCl2) exposure, and this effect partially paralleled
modifications in hepatic membrane FA composition, in the
presence and absence of PFOSA. In addition, these effects did
not parallel changes in transcript levels for FAD5, FAD6 and FAE.
The relationship between increase in the composition of hepatic
membrane FA composition and increase in FAD5, FAD6, FAE
and HIF-1a expression is interesting amidst the ongoing contro-
versy regarding the role of HIF-2 as a pro-lipogenic factor [47].
The finding showing that HIF-2a deficient mice exhibited hepatic
steatosis, and the forced expression of hepatic HIF-1a, but not
HIF-2a, that stimulated lipid accumulation in mice [48] suggests
complicated roles of HIF-1a and HIF-2a in hepatic fat accumu-
lation and possible maladaptive pathologies [43].
Previously, we showed that PFOSA produced time- and
concentration-dependent alterations in the hepatic membrane
content of several classes of FAs in salmon hepatocytes [39,49,50].
Herein, we show that exposure of cells to hypoxic conditions
produced changes in hepatic membrane FA composition, similar
to the effect of PFOSA alone, and combined exposure to hypoxia
and PFOSA, further modulated the effects of hypoxic conditions
alone. Note that these effects were based on hypoxia-inducing
compound (DFO or CoCl2), exposure time and PFOSA concen-
tration. PUFAs with 20 and 22 carbons are vital components of
membrane phospholipids, and represent key steps in cell
signalling, and control the expression of many genes involved in
lipid synthesis and metabolism, thermogenesis, and cell differen-
tiation [51]. For example, eicosanoids, including prostaglandins,
thromboxanes and leukotrienes, belong to an extensive family of
oxygenated metabolites derived from 20-carbon PUFAs such as
ARA and EPA [52], which primarily act as potent local
modulators in cells [53]. In accordance with previous findings
[39,49,50] and as demonstrated in the present study, salmon liver
is capable of FAD6-desaturation of ALA to stearidonic acid
(18:4n3) followed by elongation and FAD5 desaturation to EPA, in
addition to FAD6 desaturation of Linoleic acid (18:2n-6) to c-
linoleic acid (18:3n6) followed by elongation to Dihomo-c-
linolenic acid (DGLA, 20:3n-6) and FAD5 desaturation to ARA
[54]. Our data show that hypoxic conditions reduced several n-3
PUFAs such as ALA, DHA and EPA, which were not in
accordance with the increased expression of FAD5, FAD6 and
FAE mRNA.
Furthermore, the availability of 20- and 22-carbon polyenoic
FAs is highly dependent on the activity of FAD6, which mediates
the rate-limiting step in the production of ARA [51]. The increase
in FAD5, FAD6 and FAE mRNA expressions, three enzymes of
the FA elongation pathway, paralleled the increase in membrane
trans-linolelaidic acid (18:2n-6t) and DHA levels (but not ARA).
This discrepancy may be explained by the fact that in fish, n-3
PUFAs are abundant and play significant roles in immune
function and apoptosis [55,56]. In addition, the major regulation
mechanism of FAD6 is assumed to be pre-translational [57], and
our findings provide evidence that hypoxia increases the activity of
the elongation machinery in order to adapt to membrane and
physiological requirements due to the shortage of these FAs.
Overall, the modulation of membrane FA composition observed in
the present study predominantly involved an increase in FA
methyl esters, indicating that hypoxia, given singly and also in
combination with PFOSA, may affect lipid metabolism in Atlantic
salmon. Over-production of ARA-derived eicosanoids may be
responsible for a number of pathophysical conditions in humans,
such as atherothrombotic and chronic inflammation diseases [58].
Thus, our data suggest that changes in membrane FA levels
compensated for lipid peroxidation through an increase by
elongation and desaturation activities in order to increase
membrane fluidity as a form for compensatory mechanism. This
speculation is supported by the fact that the b-oxidation pathway
was positively enhanced in the hepatocytes after exposure to
hypoxic conditions, singly and also in combination with PFOSA
concentration (see below). Elsewhere, it has been shown that
PFOSA, PFOA and PFOS reduced lipid synthesis and increase b-
oxidation in rat in vivo system, with inconsistent changes in other
enzymes involved in lipid metabolism [59]. The report showing
that erucic acid inhibited peroxisomal b-oxidation in rats [60],
provided strong support to our observed decrease of PUFAs and
increase of mRNA levels for FA elongation enzymes and ACOX1
by hypoxic conditions, as it has been shown that PUFAs may
repress peroxisomal b-oxidation [60]. Furthermore, it has been
suggested that alteration of mRNA levels by FAs and PPAR
activators is often disconnected [61]. For example, peroxisomal
proliferators and essential FA deficient diets has been shown to
elevate the mRNA levels for FAD5 and FAD6, while dietary
Figure 3. Transcriptional changes of ACOX mRNA in salmon hepatocytes exposed to CoCl2 (150 mM) or DFO (100 mM), in presence
and absence of PFOSA (25 and 50 mM). Transcripts were analyzed using real-time polymerase chain reaction (qPCR) and expressed as mean
percentage (%) of control 6 SEM (n= 5). Asterisk (*) denotes significant difference (p,0.05) compared to control analyzed by Tukey’s test.
doi:10.1371/journal.pone.0102485.g003
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PUFAs are known to repress these genes [57]. The peroxisomal
proliferator, Wy14643, was also shown to produce delayed
induction of FAD5 and FAD6 in rats, compared to the FA
oxidation genes [57], prompting the authors to suggest that an
induction of the desaturases could occur directly because of the
degenerated direct repeat 1 (DR1) element that was reported in
human FAD6 gene and binds PPARa [57].
In the present study, the hepatic membrane FA composition
both decreased and decreased (depending on FA type, exposure
condition and time) at 24 and 48 h, after exposure to hypoxic
conditions, singly and also in combination with PFOSA concen-
tration. Overall, the n-6:n-3 ratio was either slightly reduced (50%
at 25 mM PFOSA, singly or in combination with CoCl2) or
unchanged at 24 h exposure, while at 48 h exposure a respective
Figure 4. Modulation of PPAR-a (A), PPAR-b (B) and PPAR-c (C) mRNA in salmon hepatocytes exposed to CoCl2 (150 mM) or DFO
(100 mM), singly and in combination with PFOSA (25 and 50 mM). Transcripts were analyzed using real-time polymerase chain reaction (qPCR)
and expressed as mean percentage (%) of control 6 SEM (n= 5). Asterisk (*) denotes significant difference (p,0.05) compared to control analyzed by
Tukey’s test, while diamond (¤) denotes significant difference (p,0.05) with individual hypoxia treatment group (CoCl2 or DFO) at respective time-
interval.
doi:10.1371/journal.pone.0102485.g004
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3.3- and 2.7-fold increase at 25 mM PFOSA singly or in
combination with CoCl2, and respective 5.8- and 2.3-fold increase
at DFO singly or in combination with 50 mM PFOSA, were
observed. The observed selective hypoxia and PFOSA mediated
increase in the n-6:n-3 PUFA ratio suggests a possible adaptive
response towards acute hypoxic condition, representing a suggest-
ed mechanism for membrane defense against oxidative stress
[62,63] which we are currently investigating as well (Olufsen et al.
in prep). Further on a mechanistic standpoint, whether the
increase of the elongation enzyme genes that did not parallel
decreases in certain PUFAs in salmon hepatocytes is a direct
response of hypoxic conditions and PFOSA effects in activating
PPARa, or a secondary effect that was derived from altered
membrane FA patterns, remains to be elucidated. Regardless,
these data provide significant overview on the physiological
processes that are involved in the hepatic response to hypoxic
stress, given singly or in combination with environmental
contaminants, and emphasizes the potential negative impact of
high lipid consumption on fish tolerance to environmental hypoxia
[64].
Modulation of peroxisome proliferation pathway
PPARs are important regulators of lipid and lipoprotein
metabolism, glucose homeostasis, cellular differentiation and
inflammatory responses [65,66]. Therefore, any change in FA
profile may have physiological consequences for normal mem-
brane functioning [67]. Herein, we showed that hypoxia given
singly or in combination with PFOSA produced an apparent time-
dependent change in the transcriptional level of PPAR isoforms. It
should also be noted that these transcriptional increases paralleled
increases of HIF-1a, ACOX, FAD5, FAD6 and FAE mRNA in
the combined hypoxia and PFOSA exposure groups. The
relationships between these variables were also confirmed by the
PCA showing clustering of combined exposure groups and
distribution of samples after 48 h. Different distribution pattern
at 24 and 48 h in the PCA bi-plot, implies that changes in mRNA
responsiveness is time-dependent.
The role of PPARa in physiological processes such during
angiogenesis has been investigated under hypoxia condition [68]
and reviewed by [69], showing inductive and inhibitory effects
[69]. For example, mitochondrial FA oxidative capacity was
reduced by hypoxia, resulting in reduced mitochondrial lipid
mobilization and utilization, and consequent accumulation of
intracellular neutral lipid [70]. In another study, cardiomyocytes
increased oxygen utilization efficiency by switching from FA
oxidation to glycolysis under hypoxic conditions, and this shift of
metabolic substrate was achieved by HIF-1-induced increase of
the expression of glucose transporters and glycolytic enzymes
[71,72], and PPARa/RXR-mediated suppression of mitochon-
drial FA b-oxidation [70,73]. Using two different in vivo systemic
hypoxia models (CoCl2 and iso-volemic hemodilution), Razeghi
and co-workers [74] reported a decrease in the expression of
PPARa and several PPARa target genes including (pyruvate
dehydrogenase kinase 4 (PDK4), muscle carnitine palmitoyltrans-
ferase-I (mCPT-I), and malonyl-CoA decarboxylase (MCD) in rat
heart, and suggests a potential transcriptional mechanism for the
decrease in long chain fatty acyl-CoA oxidation during hypoxia
[74]. When the above mentioned reports are viewed with our data
showing increased HIF-1a expression that paralleled PPAR
isoforms, including PPARa – there are discrepancies as has been
reported previously [69], regarding the cellular mechanism of
peroxisomal b-oxidation towards hypoxia adaptation. It should be
noted that we observed significant alterations of membrane FA
profile towards hypoxia exposure. When the changes in mem-
brane FA profile and PPARs data are taken together, there is a
potential that hypoxia increased the level of endogenous ligands
for all PPARs in salmon hepatocytes. This argument is supported
by the observation showing no differences between PPAR
isoforms, which were all increased by hypoxia exposure alone or
in combination with PFOSA.
During normal physiological conditions, there is an inverse
relationship between PPAR isoforms, where PPAR-a and PPAR-b
show similar expression patterns [75], and share some endogenous
ligands [17,76], while PPAR-c have a dissimilar function and
other endogenous ligands [77]. In accordance with the present
findings, hypoxia has previously shown to induce PPAR-c
expression [78]. While the mechanism for this effect is unclear,
a possible mechanism to conserve energy during sub-optimal
conditions was proposed [79]. Overall, while DFO induces
hypoxia by chelating iron for excretion and subsequently reducing
the potential for oxygen transport [29], CoCl2 is a transition metal
that replaces iron in heme proteins, but does not bind oxygen,
contrary to iron, when incorporated to protoporhyrins [80]. The
entire iron replacement produces an oxygen sensor signal to the
cell that mimics a state of oxygen reduction [74,80]. The DFO and
CoCl2 mechanisms induced hypoxia gene marker in hepatocytes
and whether these represent a generalized mechanism in all cells
remains to be investigated. However, other hypoxia parameters
than HIF-1a, such as HIF-2a are responsible for PPAR regulation
[81], that could further explain the changes in FA profile observed
in the present study.
Regardless, we reported recently that PFOA, PFOS and
PFOSA modulated lipid homeostasis and PPAR transcription in
salmon in vivo and in vitro systems [39,50]. It has also been
suggested that certain POPs can interact with transcription factors
in a similar manner as FAs, acting as a PPAR agonist [82]. Given
that salmonid tissues are characterized by high concentrations of
PUFAs, making them prone to oxidative damage [83] and fish are
more protected from lipid peroxidation than mammals [83], the
present data provide significant insight on the effects of hypoxia on
cellular lipid homeostasis. Combined hypoxia and PFOSA
exposures increased PPAR isoforms, suggesting that these
emerging environmental stressors produced peroxisomal prolifer-
ation in salmon hepatocytes. Furthermore, PPARc could be
involved in the regulation of the peroxisomal b-oxidation pathway
in Atlantic salmon [84,85]. Long-chain FAs, which are exclusively
metabolized in the peroxisomes, exert an inhibitory effect on the
peroxisomal b-oxidation [60]. Therefore, the activation of the
elongation pathway could therefore explain the increased expres-
sion of ACOX1 that was observed after exposure to combined
hypoxia and PFOSA. ACOX catalyses the rate limiting-step in
peroxisomal b-oxidation pathway of FA, and is commonly used as
a biomarker for peroxisomal proliferation [86]. The role of
PPARc in fat accumulation, adipocyte differentiation and immune
Figure 5. Biplot of principal component analysis (PCA) showing the scattering of HIF-1a, FAD5, FAD6, FAE, ACOX and PPAR (a, b
and c) mRNA levels after either 24 h (A) or 48 h (B) of exposure. Salmon hepatocytes were exposed to CoCl2 (150 mM) or DFO (100 mM)
singly or in combination with PFOSA (25 and 50 mM) and gene expression was analyzed by qPCR. Letter denotes exposure treatment (A-Solvent
control; B-25 mM PFOSA; C-50 mM PFOSA; D-50 mM CoCl2; E-25 mM PFOSA+150 mM CoCl2; F-50 mM PFOSA+150 mM CoCl2; G-100 mM DFO; H-25 mM
PFOSA+100 mM DFO; I-50 mM PFOSA+100 mM DFO) and followed by a number (1–10) denoting the individual sample.
doi:10.1371/journal.pone.0102485.g005
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response, lipid and carbohydrate metabolism has been reported
[87]. Particularly, an antagonistic interaction between PPARa and
PPARc in the maintenance of lipid homeostasis [88] has been
suggested. Contrary to previous findings by Wa˚gbø et al (2012)
showing distinct and apparent concentration-dependent transcrip-
tional increase of PPARc by PFOSA exposure of salmon
hepatocytes [85], the present study showed a comparable pattern
of expression between PPARc and PPARa after combined
exposure to hypoxia and PFOSA.
Increased oxidative stress and lipid peroxidation in salmon fed a
diet containing PFOS and PFOA was reported [49]. ROS
accumulation is a potentially harmful outcome of systemic hypoxia
[5,89,90], and increased peroxisome proliferation may worsen the
situation by adding to ROS load [91]. Lipid peroxidation
produces alteration in membrane lipid structure that may affect
membrane lipids and change in functionality [91,92]. Our data
demonstrate increased PPAR transcription in combined hypoxia
and PFOSA exposure, compared to single exposures, supporting
the significance of multiple stressor investigations.
In summary, alteration of FAD5, FAD6 and FAE gene
expression were generally more affected by hypoxia than PFOSA
and combined exposure produced stronger effects than hypoxia
alone. Regulation of lipid homeostasis is a very complex process
with a myriad of pathways in the energetic budget and link to the
immune system. Increased peroxisome proliferation may have
detrimental effects due to alteration of lipid homeostasis and
directly by increasing lipid peroxidation. Our data show that
PPARs (a, b and c) transcription were increased and these
responses were stronger in hepatocytes experiencing combined
hypoxia and PFOSA exposure. The combined effects of hypoxia
and PFOSA on lipid homeostasis and b-oxidation in salmon
hepatocytes suggest that these emerging multiple environmental
stressors evoke deleterious effects with potential overt physiological
consequences for development, reproduction and general health.
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